Organogenesis Holdings (ORGO) Operating Expenses (2016 - 2026)

Organogenesis Holdings' Operating Expenses history runs 11 years deep, the most recent figure standing at $106.1 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 6.45% year-over-year to $106.1 million; the TTM figure through Mar 2026 stood at $219.9 million (up 51767.45% YoY), while the FY2025 annual figure was $137.5 million, up 18.82% from the prior year.
• Operating Expenses was $106.1 million for Q1 2026 at Organogenesis Holdings, up from $49.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $113.4 million in Q1 2025 to a low of -$251.1 million in Q4 2024.
• Historically, Operating Expenses has averaged $43.3 million across 5 years, with a median of $79.7 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses plunged 268.79% in 2023, then soared 119.88% in 2025.
• A 5-year view of Operating Expenses shows it stood at $79.7 million in 2022, then slumped by 268.79% to -$134.5 million in 2023, then slumped by 86.72% to -$251.1 million in 2024, then jumped by 119.88% to $49.9 million in 2025, then soared by 112.59% to $106.1 million in 2026.
• The last three Operating Expenses figures came in at $106.1 million (Q1 2026), $49.9 million (Q4 2025), and $36.3 million (Q3 2025), per Business Quant data.